QuickView for ku55933 (compound)

1. B cells from bone marrows of humanized NSG mice treated with ATM inhibitor KU55933
2. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
3. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
4. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

1. Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer.
2. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose up…
3. Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using …
4. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell da…
5. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.

There were no clinical trials for ku55933